VEGF Receptor 2 Kinase Inhibitor I(CAS: 15966-93-5)

VEGF Receptor 2 Kinase Inhibitor I (CAS: 15966-93-5) is a crystalline compound with a molecular weight of approximately 544.7 g/mol. It has a high solubility in DMSO and moderate solubility in water. This inhibitor is known for its low reactivity under normal conditions but can undergo hydrolysis in the presence of moisture. Its physical properties include a melting point of around 150°C and a density of approximately 1.2 g/cm³.

VEGF Receptor 2 Kinase Inhibitor I (CAS: 15966-93-5) is typically synthesized through multi-step organic synthesis involving the coupling of aryl halides with amines under palladium catalysis. The synthesis requires careful control of reaction conditions, including temperature and solvent selection. The final product is isolated by recrystallization from appropriate solvents, yielding a purified compound with a high degree of selectivity and a yield of about 70%.

VEGF Receptor 2 Kinase Inhibitor I (CAS: 15966-93-5) is primarily used in the pharmaceutical industry for the development of targeted cancer therapies. It is also relevant in the biotech sector for research and development of new kinase inhibitors. Additionally, it can be utilized in academic and industrial laboratories for studying receptor tyrosine kinases and their role in various biological processes.

When handling VEGF Receptor 2 Kinase Inhibitor I (CAS: 15966-93-5), it is crucial to wear appropriate personal protective equipment (PPE), including gloves and safety goggles. Store the compound in a cool, dry place away from direct sunlight and moisture. Always use a fume hood during handling to minimize inhalation risks. In case of a spill, immediately clean up using appropriate materials and consult the Safety Data Sheet (SDS) for detailed instructions.